Iron Deficiency in Heart Failure: to Treat or Not to Treat?

Current Treatment Options in Cardiovascular Medicine
Michael Pope, Paul R Kalra

Abstract

This review will highlight the frequency and prognostic importance of iron deficiency in patients with chronic heart failure. An overview of the evidence surrounding the use of both oral and intravenous iron will be presented together with discussion around what further data are required to establish what is the optimal long-term treatment strategy. Several recent randomised controlled studies have suggested that intravenous iron therapy in iron deficient patients with chronic heart failure and reduced ejection fraction can improve symptoms and quality of life, at least in the short term. There is no evidence of benefit from oral iron. Iron deficiency is common in patients with chronic heart failure and is associated with a worse prognosis. Whilst oral iron therapy has been shown to be of no benefit, randomised controlled trials suggest significant improvement in symptoms and quality of life with intravenous iron treatment over 6-12 months. Data are lacking on long-term efficacy, safety and impact on hard outcomes such as death and hospitalisation. Four large trials are currently recruiting patients and will provide definitive answers to these outstanding questions.

References

Sep 1, 2004·Journal of the American College of Cardiology·G Michael FelkerChristopher M O'Connor
Sep 19, 2006·Journal of the American College of Cardiology·Aidan P BolgerCallum M Chapman
Oct 24, 2007·Journal of the American College of Cardiology·Jorge Eduardo ToblliFederico Di Gennaro
Nov 19, 2009·The New England Journal of Medicine·Stefan D AnkerUNKNOWN FAIR-HF Trial Investigators
Jun 24, 2010·European Heart Journal·Ewa A JankowskaPiotr Ponikowski
Oct 5, 2010·Annual Review of Medicine·Tomas Ganz, Elizabeta Nemeth
May 27, 2011·European Journal of Heart Failure·Stephan von HaehlingStefan D Anker
Sep 10, 2011·Journal of the American College of Cardiology·Darlington O OkonkoPhilip A Poole-Wilson
Oct 27, 2012·European Heart Journal·Ewa A JankowskaPiotr Ponikowski
Mar 12, 2013·The New England Journal of Medicine·Karl SwedbergUNKNOWN RED-HF Investigators
Mar 30, 2013·American Heart Journal·Ijsbrand T KlipEwa A Jankowska
May 18, 2013·International Journal of Cardiology·Luís Beck-da-SilvaNadine Clausell
Feb 3, 2015·European Journal of Heart Failure·Theresa McDonagh, Iain C Macdougall
Apr 4, 2017·Hemodialysis International·Michael Auerbach, Iain Macdougall
May 17, 2017·JAMA : the Journal of the American Medical Association·Gregory D LewisUNKNOWN NHLBI Heart Failure Clinical Research Network
Jul 14, 2017·Circulation·Dirk J van VeldhuisenUNKNOWN EFFECT-HF Investigators
Aug 25, 2017·Cardiovascular Therapeutics·Chan-Keat KangPaul R Kalra

❮ Previous
Next ❯

Citations

Dec 21, 2018·The Journal of Physiological Sciences : JPS·Ei Ei MonKazuhito Tomizawa
Apr 25, 2019·Heart Failure Reviews·Mihai LupuGabriela Adriana Filip
Dec 15, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jiayin GaoLinxi Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.